Emkay Global Financial Services is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 504 in its February 23, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!